Trulieve Executive Explains Georgia's Expanded Medical Marijuana Program

Program Expansion Overview

Georgia's medical marijuana program has expanded from eight qualifying conditions at launch to 19 conditions as of mid-2026, according to the Trulieve executive briefing. The additions include chronic pain, severe arthritis, and post-traumatic stress disorder, which collectively account for the majority of new patient registrations since 2024. The Georgia Access to Medical Cannabis Commission approved the expanded list in March 2026 following a two-year review process mandated by the Georgia General Assembly.

The state now operates 14 licensed dispensaries statewide, up from the initial six that opened in 2023. Trulieve holds two of Georgia's 10 production licenses. It operates three dispensary locations in metro Atlanta, Savannah, and Augusta.

Patient Registration Growth

Registered patients in Georgia's program reached 27,400 as of June 2026, a 340 percent increase from the 6,200 patients enrolled at the end of 2023. The Trulieve executive attributed the growth to the expanded qualifying conditions list and streamlined physician certification processes introduced in January 2025. Georgia law requires patients to obtain certification from a physician registered with the state's Low THC Oil Registry, a requirement that initially limited program participation.

In 2025, the state reduced the physician registration fee from $250 to $50. That change resulted in 1,100 certified physicians as of July 2026 compared to 340 in 2023. The improved physician-to-patient ratio has shortened average wait times for certification appointments from six weeks to under two weeks statewide.

Product Availability and Limits

Georgia's program restricts THC content to 5 percent for flower products and limits patients to purchasing 20 ounces of low-THC oil per 30-day period. The executive confirmed that Trulieve's Georgia operations stock tinctures, capsules, topicals, and flower products that comply with the state's THC caps. Georgia remains one of seven states that impose percentage-based THC limits rather than total quantity restrictions.

The 20-ounce limit translates to approximately 5,600 milligrams of THC per month for a patient using 5 percent THC oil exclusively, according to state dosage calculations. Trulieve reported average monthly patient purchases of 12 ounces of product across its Georgia locations. Most patients operate well below the statutory cap.

Dispensary Access Challenges

Rural access remains the program's primary operational challenge, with eight of Georgia's 159 counties located more than 75 miles from the nearest dispensary. Trulieve has applied for two additional dispensary licenses in South Georgia to address the access gap, pending Georgia Access to Medical Cannabis Commission approval expected in Q4 2026. State law caps total dispensary licenses at 30, with no single operator permitted to hold more than five retail locations.

Since 2025, the commission has prioritized rural license applications, awarding four of the last six dispensary licenses to operators proposing locations in counties with populations under 50,000. Trulieve's pending applications target Valdosta and Albany, which would serve 11 currently underserved counties in the state's southwest region.

Pricing and Insurance Considerations

Georgia medical cannabis products aren't covered by any insurance plans, and the average monthly patient expenditure at Trulieve Georgia locations is $320, according to the executive. That figure includes product costs, state registration fees, and physician certification expenses. The Georgia Low THC Oil Registry charges patients a $25 annual registration fee. Physician certification visits range from $150 to $300 depending on provider and location.

Trulieve offers a 10 percent discount for veterans, seniors over 65, and patients receiving Social Security disability benefits. Approximately 30 percent of Trulieve's Georgia patient base qualifies for the discount program, the executive stated.

Regulatory Compliance Framework

The Georgia Access to Medical Cannabis Commission conducts quarterly audits of all licensed production facilities and dispensaries, with violations resulting in fines ranging from $5,000 to $50,000 per incident. Trulieve's Georgia operations have received zero compliance violations since launch, according to commission records reviewed during the briefing. Metrc, the state's track-and-trace system, monitors all product movement from cultivation through final sale.

Georgia law prohibits smokable flower sales to patients under 18, requires child-resistant packaging for all products, and mandates third-party lab testing for potency, pesticides, heavy metals, and microbial contaminants. Trulieve uses two independent Georgia-licensed labs for compliance testing. Results are posted to the state registry within 48 hours of each batch release.

Next Steps for Program Development

The Georgia General Assembly is expected to consider legislation in the 2027 session that would eliminate the 5 percent THC cap on flower products and expand home cultivation rights for registered patients. The Trulieve executive declined to comment on pending legislation but confirmed that the company has submitted formal comments to the commission supporting the removal of percentage-based THC limits in favor of total quantity purchase caps.

For comprehensive background on Georgia's medical cannabis regulatory framework and patient enrollment trends, see the CannIntel topic hub on the Georgia Medical Marijuana Program. The commission's next quarterly meeting is scheduled for September 18, 2026. Agenda items include the rural dispensary license awards and a review of the expanded qualifying conditions list.